Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Influenza Diagnostic Market Value Analysis: What Growth Is Expected Over The Forecast Period?
The influenza diagnostic market size has grown strongly in recent years. It will grow from $2.87 billion in 2025 to $3.1 billion in 2026 at a compound annual growth rate (CAGR) of 8.3%. The growth in the historic period can be attributed to seasonal influenza outbreaks, widespread use of rapid antigen tests, growth of hospital laboratory infrastructure, government influenza surveillance programs, increased awareness of early flu diagnosis.
The influenza diagnostic market size is expected to see strong growth in the next few years. It will grow to $4.19 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to rising frequency of influenza epidemics, growing demand for accurate molecular diagnostics, expansion of point-of-care testing facilities, increased public health preparedness initiatives, technological advancements in rapid diagnostic assays. Major trends in the forecast period include rising demand for rapid influenza testing, increased adoption of molecular diagnostic methods, growing preference for point-of-care flu diagnostics, expansion of seasonal and pandemic surveillance testing, continuous improvement in test sensitivity and specificity.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp
Influenza Diagnostic Market Growth Factors: Which Forces Are Supporting Market Expansion?
The increasing funding for research on influenza diagnostics is expected to propel the growth of the influenza diagnostic market going forward. Funding for research on influenza diagnostics refers to financial resources allocated by government agencies, institutions, and organizations to support scientific investigations aimed at developing, improving, and validating methods and technologies for detecting and identifying influenza viruses. The rising funding for influenza research is driven by lessons learned from the COVID-19 pandemic and concerns about future respiratory disease outbreaks, as health authorities recognize the critical importance of rapid and accurate diagnostic capabilities to prevent widespread transmission and enable timely public health interventions. Growing research funding supports the development and commercialization of advanced testing technologies, molecular assays, point-of-care devices, and improved laboratory procedures that enable faster and more accurate identification of influenza strains in clinical settings. For instance, in October 2024, according to the Department of Health and Aged Care, a Australia-based government organization responsible for health research, funding, promotion and regulation, the Australian Government is allocating $95 million to combat avian influenza, protecting agriculture, wildlife, and the economy. Therefore, increasing funding for research on influenza diagnostics is driving the growth of the influenza diagnostic market.
Influenza Diagnostic Market Categorization By Product Type And Application
The influenza diagnostic market covered in this report is segmented –
1) By Traditional Diagnostic Tests: Rapid Influenza Diagnostic Tests (RIDT), Viral Culture, DFA, Serological Assays, Other Traditional Diagnostic Tests
2) By Molecular Diagnostic Tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests
3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users
Subsegments:
1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)
2) By Viral Culture: Cell Culture, Egg-based Culture
3) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay
4) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays
Influenza Diagnostic Market Industry Trends: What Changes Are Reshaping Demand?
Major companies operating in the influenza diagnostic market are developing innovative products such as Lucira COVID-19 & Flu Home Test for the simultaneous rapid qualitative detection. The Lucira COVID-19 and Flu Home Test is a single-use at-home test kit that provides results from self-collected nasal swab samples in roughly 30 minutes. For instance, in February 2023, Pfizer Inc., a US-based pharmaceutical company received approval for the Lucira COVID-19 & Flu Home Test. The test can detect influenza A and B, commonly known as the flu, and SARS-CoV-2, the virus that causes COVID-19.
Influenza Diagnostic Market Company Landscape And Strategic Competition
Major companies operating in the influenza diagnostic market are F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc.
Access The Complete Influenza Diagnostic Market Report:
https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report
Influenza Diagnostic Market Largest Region: Which Geography Holds The Highest Market Share?
North Americawas the largest region in the influenza diagnostics market in 2025. Western Europewas the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
